Cost of Health Care-Associated Infections in the United States
- PMID: 33881808
- DOI: 10.1097/PTS.0000000000000845
Cost of Health Care-Associated Infections in the United States
Abstract
Background: Health care-associated infections (HAIs) are costly, and existing national cost estimates are out-of-date.
Methods: We retrospectively analyzed the Agency for Healthcare Cost and Utilization Project's 2016 National Inpatient Sample, the largest all-payer U.S. inpatient database. We included all inpatient encounters with primary or secondary International Classification of Disease, 10th Revision Clinical Modification diagnosis codes corresponding to infection with catheter-associated urinary tract infections (T85.511), catheter- and line-associated blood stream infections (T80.211), surgical site infections (SSIs; T81.49), ventilator-associated pneumonias (J95.851), and Infection with Clostridioides difficile (CDI; A04.7). We combined HAI incidence data from the National Inpatient Sample with additional hospital inpatient HAI cost estimates to create national cost estimates for HAI individually and collectively.
Results: In 2016, 7.2 to 14.9 billion U.S. dollars were spent on HAIs in the United States. For admissions with any diagnosis of HAI, the frequencies of HAI in descending order were as follows: CDI (n = 356,754 [56%]), SSI (n = 196,215 [31%]), catheter- and line-associated blood stream infection (n = 42,811 [7%]), catheter-associated urinary tract infection (n = 23,546 [4%]), and ventilator-associated pneumonia (n = 16,767 [3%]). Collectively, CDI and SSI accounted for 79% of the cost of HAI in the United States.
Conclusions: Health care-associated infections remain a significant economic burden for health care systems in the United States.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors disclose no conflict of interest.
References
-
- Scott R II. In: Polock DA, Stone PW, eds. The Direct Medical Costs of Healthcare-Associated Infections in US Hospitals and the Benefits of Prevention. Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention . London, UK: Economist; 2009.
-
- Zimlichman E, Henderson D, Tamir O, et al. Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med . 2013;173:2039–2046.
-
- Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital-Acquired Conditions . Rockville, MD: Agency for Healthcare Research and Quality. Content last reviewed November 2017. Available at: https://www.ahrq.gov/sites/default/files/publications2/files/hac-cost-re... . Accessed December 18, 2020.
-
- Agency for Healthcare Research and Quality. Introduction to the HCUP National Inpatient Sample (NIS) 2016. Healthcare Cost and Utilization Project . Rockville, MD: Agency for Healthcare Research and Quality.
-
- Martone WJ, Jarvis WR, Culver DH, et al. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital Infections . Boston: Little, Brown, and Company; 1992:577–596.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical